Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2467449019 | Oral azapropazone (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
2473606012 | Oral azapropazone | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
2727032014 | Oral form azapropazone (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
2770163014 | Oral form azapropazone | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
3486832015 | Product containing azapropazone in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
3495200019 | Product containing azapropazone in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3495201015 | Azapropazone in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3495202010 | Apazone in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3495203017 | Product containing apazone in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3708669016 | Azapropazone-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3708670015 | Product containing azapropazone in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3708671016 | Apazone-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
105051601000001119 | Oral form azapropazone | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing azapropazone in oral dose form (medicinal product form) | Is a | Product containing azapropazone | true | Inferred relationship | Existential restriction modifier | ||
Product containing azapropazone in oral dose form (medicinal product form) | Has active ingredient | Azapropazone | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing azapropazone in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing azapropazone in oral dose form (medicinal product form) | Is a | Product manufactured as oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing azapropazone in oral dose form (medicinal product form) | Plays role | Uricosuric therapeutic role | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely azapropazone 300 milligram/1 each conventional release oral capsule | Is a | False | Product containing azapropazone in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
Product containing precisely azapropazone 600 milligram/1 each conventional release oral tablet | Is a | False | Product containing azapropazone in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
Product containing only azapropazone in oral dose form (medicinal product form) | Is a | True | Product containing azapropazone in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets